Announcements Trials
Browse Landscape Eligibility

Clinical Trials

4 trials
RecentStart dateEnrollment
ESCC × Clear all

Phase

Phase NA 2Phase 2 1Phase 1/2 1

Status

Unknown 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 11735Neoplasms 9361Carcinoma, Non-Small-Cell Lung 6100Prostatic Neoplasms 5640Colorectal Neoplasms 5275Lung Neoplasms 4518Multiple Myeloma 3186Pancreatic Neoplasms 3174Neoplasm Metastasis 3120Leukemia, Myeloid, Acute 3104Carcinoma, Hepatocellular 2907Ovarian Neoplasms 2832Melanoma 2805Stomach Neoplasms 2722Lymphoma 2681Head and Neck Neoplasms 2313Recurrence 2268Precursor Cell Lymphoblastic Leukemia-Lymphoma 2207Leukemia 2131Brain Neoplasms 2099Colonic Neoplasms 2065Lymphoma, Non-Hodgkin 2019Rectal Neoplasms 1955Uterine Cervical Neoplasms 1910Glioblastoma 1813Leukemia, Lymphocytic, Chronic, B-Cell 1776Carcinoma, Renal Cell 1700Squamous Cell Carcinoma of Head and Neck 1651Lymphoma, Follicular 1631Esophageal Neoplasms 1603

Interventions

trifluridine tipiracil drug combination 1camrelizumab 1anlotinib 1Radiotherapy 1Induction Chemotherapy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT07196345 2025-09-29

TAS-102 Plus Radiotherapy in Elderly ESCC

Qianfoshan Hospital

Phase 1/2 Not yet recruiting
45 enrolled

ESCC

NCT07015489 2025-06-11

Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Completed
44 enrolled

ESCC

NCT05050760 2023-01-31

DCF Combined With Camrelizumab in the Treatment of Esophageal Cancer

Xijing Hospital

Phase NA Unknown
55 enrolled

ESCC

NCT04471480 2020-07-15

TC

Third Military Medical University

Phase NA Unknown
90 enrolled

ESCC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡